(Q83593112)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337429%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

review article

1 reference

title

Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337429%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

1 reference

Daanish Hoda

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337429%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

George R Simon

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337429%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Christopher R Garrett

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337429%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

1 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337429%20AND%20SRC:MED&resulttype=core&format=json

Therapeutics and Clinical Risk Management

25 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337429%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337429%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337429%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

1221-1227

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337429%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial 3.0 Unported

25 January 2020

copyright license

start time

1 December 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Tumors established with cell lines selected for oxaliplatin resistance respond to oxaliplatin if combined with cetuximab

1 reference

12 December 2020

Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts

1 reference

12 December 2020

Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers.

1 reference

12 December 2020

Survival of cancer cells is maintained by EGFR independent of its kinase activity

1 reference

12 December 2020

A kinase-negative epidermal growth factor receptor that retains the capacity to stimulate DNA synthesis

1 reference

12 December 2020

The epidermal growth factor receptor as a target for colorectal cancer therapy

1 reference

12 December 2020

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

1 reference

12 December 2020

Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinoma

1 reference

12 December 2020

Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody

1 reference

12 December 2020

Dose and schedule study of panitumumab monotherapy in patients with advanced solid malignancies

1 reference

12 December 2020

Targeting the epidermal growth factor receptor for cancer therapy

1 reference

12 December 2020

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

1 reference

12 December 2020

Panitumumab monotherapy in patients with previously treated metastatic colorectal cancer

1 reference

12 December 2020

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

1 reference

12 December 2020

Clinical presentation and pathophysiology of EGFRI dermatologic toxicities

1 reference

12 December 2020

Epidermal growth factor receptor blockade by antibody IMC-C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice

1 reference

12 December 2020

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

1 reference

12 December 2020

Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy

1 reference

12 December 2020

Pathology and management of dermatologic toxicities associated with anti-EGFR therapy

1 reference

12 December 2020

Ligand- and kinase activity-independent cell survival mediated by the epidermal growth factor receptor expressed in 32D cells

1 reference

12 December 2020

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer

1 reference

12 December 2020

Responsiveness to cetuximab without mutations in EGFR.

1 reference

12 December 2020

Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab

1 reference

12 December 2020

Single-molecule imaging of EGFR signalling on the surface of living cells

1 reference

12 December 2020

Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors

1 reference

12 December 2020

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

1 reference

12 December 2020

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

12 December 2020

Identifiers

DOI

10.2147/TCRM.S4314

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337429%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337429%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

PubMed publication ID

19337429

1 reference